National and Kapodistrian University of Athens
Η επίδραση της συνεχούς θετικής πίεσης αεραγωγών (CPAP) και ο ρόλος της χρονοθεραπευτικής στη ρύθμιση της αρτηριακής πίεσης σε υπερτασικούς ασθενείς με σύνδρομο αποφρακτικής άπνοιας-υπόπνοιας ύπνου
Abstract
dc:descriptionObjective: Patients with Obstructive Sleep Apnea (OSA) are often hypertensive, and Continuous Positive Airway Pressure (CPAP) may improve levels and nighttime behavior of blood pressure (BP). As asymptomatic patients with OSA often refuse to follow CPAP treatment, we investigated the efficacy of different dosing times of antihypertensive drugs on BP management in this setting.Design and Method: In this prospective, 16-week, open-label, cross-over, stable-dose chronotherapy trial, we studied 41 patients (aged 52±8 years, 78% males) with newly diagnosed hypertension and never treated, at least moderate OSA (apnea-hypopnea index-AHI:37±20/hour), without daytime sleepiness (Epworth Sleepiness Scale Score≤10 points). Patients were first applied treatment with valsartan (stage I hypertension) or combined valsartan/amlodipine (stage II hypertension) in a single morning dose for 8-weeks. In a second period of 8-weeks, patients were assigned to receive the same regimen in a single evening dose before bedtime. Office and ambulatory BP were measured at baseline and after each treatment phase. Based on concurrent start of CPAP application, patients were divided into two groups: on-CPAP (n=20) and off-CPAP (n=21).Results: Sixteen patients had stage I and 25 patients had stage II hypertension. Office BP was significantly reduced at the end of both the morning and evening dosing phases compared to baseline (by 19.4±11.0/15.0±8.6mmHg and 23.1±11/16.7±8.4mmHg, repeated measures ANOVA p<0.001). Evening dosing was accompanied by a significant further decrease of office systolic BP (by 3.7±6.5mmHg, p=0.002). The decrease in 24-hour BP was significant but similar in the two dosing times (by 16.4±11/11.0±7.5mmHg and 18.4±11/12.1±7.5mmHg, p<0.001). However, evening compared to morning dosing caused a further reduction in nighttime BP by 4.4±8.6/2.9±5.6mmHg (p=0.007 and 0.006 respectively). Prevalence of nighttime dipping increased from 24% at baseline modestly to 34% with the morning dose and significantly to 61% with the evening dose. There was no significant association between CPAP application and changes in BP parameters. BP variability and morning surge were similar among the treatment phases. Conclusions: Evening compared to morning dosing of antihypertensive treatment is more effective in improving nighttime BP levels and dipping status in non-sleepy patients with OSA, irrespective of application of CPAP. The effect of CPAP on BP is not identifiable over the application of conventional antihypertensive treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kasiakogias, Alexandros
- Κασιακόγιας, Αλέξανδρος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39094